Indication
Articular Cartilage Defect
3 clinical trials
3 products
Product
MACIClinical trial
A Prospective, Open-label, Randomized, Concurrent Active-controlled, Longitudinal, Multicenter, Phase 3 Clinical Study of the Safety and Efficacy of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the KneeStatus: Recruiting, Estimated PCD: 2027-06-01
Clinical trial
A Multi-Center, Open-Label, Phase 2 Trial to Evaluate the Efficacy and Safety of CartiLife® for Patients With Articular Cartilage Defects in the KneeStatus: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
Safety and Efficacy of NOVOCART 3D in the Treatment of Articular Cartilage Defects Following Failure on MicrofractureStatus: Recruiting, Estimated PCD: 2025-12-01
Product
NOVOCART 3D